Literature DB >> 31785615

Indications for extrahepatic bile duct resection due to perineural invasion in patients with gallbladder cancer.

Suguru Maruyama1, Hiromichi Kawaida1, Naohiro Hosomura1, Hidetake Amemiya1, Ryo Saito1, Hiroki Shimizu1, Shinji Furuya1, Hidenori Akaike1, Yoshihiko Kawaguchi1, Makoto Sudo1, Shingo Inoue1, Hiroshi Kono1, Daisuke Ichikawa2.   

Abstract

BACKGROUND: The indications for extrahepatic bile duct (EHBD) resection remain a major controversy in the surgical management of patients with gallbladder cancer. On the other hand, perineural invasion (PNI) was reported as an important factor in patients with gallbladder cancer because gallbladder cancer cells frequently spread to the tissues surrounding the EHBD via perineural routes. We assessed the correlation of PNI with clinicopathological factors in patients with gallbladder cancer to elucidate EHBD resection indications specifically in patients with PNI.
METHODS: This retrospective study assessed the PNI status of 50 patients with gallbladder cancer who underwent curative resection and examined the correlation between the presence of PNI and clinicopathological factors.
RESULTS: Thirteen patients (26%) were PNI positive. PNI was significantly correlated with male sex, proximal-type tumor, lymphatic and vascular invasion, and advanced T stage. Multivariate analysis found that PNI positivity (p < 0.001), lymphatic invasion (p = 0.007), and nodal stage (p < 0.001) were independent prognostic factors. PNI was never observed in patients with stage T1 cancer. Conversely, PNI was detected rarely in distal-type tumors, all of whom developed various types of recurrences.
CONCLUSIONS: These results clearly demonstrated the prognostic impact of PNI in patients with gallbladder cancer. We suggest that EHBD resection in combination with cholecystectomy may not be useful for distal-type tumors from a perspective of PNI.

Entities:  

Keywords:  Extrahepatic bile duct resection; Gallbladder cancer; Perineural invasion

Mesh:

Year:  2019        PMID: 31785615      PMCID: PMC6885324          DOI: 10.1186/s12957-019-1735-0

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


Introduction

Gallbladder cancer is recognized as one of the most aggressive tumors, with a dismal prognosis [1]; even after curative surgery, the prognosis ranges from 17 to 45% [2]. In addition to aggressive nature of cancer, the anatomic features of the gallbladder such as the absence of a submucosal layer and close proximity to the liver and the hepatoduodenal ligament can encourage progression and spread of the lethal disease [3, 4]. Curative surgical resection (R0) is the only treatment approach that can provide long-term survival, and procedures vary depending on the extent of the tumor spread [5]. Some studies recommend radical cholecystectomy with extrahepatic bile duct (EHBD) resection in patients with gallbladder cancer even in the absence of direct invasion to the hepatoduodenal ligament based on studies showing that gallbladder cancer cells frequently spread to the tissues surrounding the EHBD via perineural and lymphatic routes [6, 7]. In fact, the dense neural network comprising nerve fibers and plexuses circumvolutes EHBD. Furthermore, there is abundant nerve tissue surrounding the gallbladder and the bile duct [8]. Tumor cells can also spread through the perineural space. Importantly, perineural invasion (PNI) was reported as a significant prognostic factor in patients with gallbladder cancer [6, 9]. At our institution, as a principle, we have been performing radical cholecystectomy with EHBD resection in patients with gallbladder cancer except for those patients with mucosal cancer. In the current study, we assessed correlations between PNI and clinicopathological factors in patients with gallbladder cancer who underwent surgical resection with or without EHBD resection and elucidated the indications for EHBD resection with a focus on the clinical significance of PNI.

Methods

Patients

Between 2001 and 2017, 68 patients with gallbladder cancer underwent surgical resection at the University of Yamanashi Hospital. Patients who underwent non-curative resection were excluded from the study. Thus, 50 patients who underwent surgery were included in this retrospective study. We diagnosed all cases as gallbladder cancer using computed tomography (CT), magnetic resonance imaging (MRI), and endoscopic ultrasound (EUS) before surgery; therefore, there was no incidental cancer. None of the patients received preoperative chemotherapy or chemoradiotherapy. In principle, cholecystectomy with EHBD resection was performed in patients with gallbladder cancer except for those patients with mucosal cancer. The clinicopathological features of the cases were reviewed based on data recorded in the hospital database. Tumor specimens and resected lymph nodes were obtained at the time of surgery, fixed immediately in 10% neutral-buffered formalin, and embedded in paraffin. Macroscopic and microscopic classification of gallbladder cancer was based on the Union for International Cancer Control classification, 7th edition. Complications were defined using the Clavien classification, and grade ≥ 2 complications were recorded [10]. Tumors invading the neck or the cystic duct of the gallbladder were defined as proximal-type, and those localized in the body or the fundus were defined as distal-type. Circumferential tumor locations were categorized as hepatic and non-hepatic, and circumferential involvement was recorded as hepatic. Postoperative follow-up comprised evaluation of hematological parameters, computed tomography, and ultrasonography. Follow-up procedures were performed every 3 months for at least 2 years and subsequently continued periodically for at least 5 years. The study was approved by the Ethics Committee of the Yamanashi University and performed in accordance with the ethical standards of the Declaration of Helsinki and its later amendments.

Statistical analysis

Comparisons between two groups were made using the Student’s t test. Associations between PNI and categorical variables were evaluated using the χ2 test. Survival curves were constructed using the Kaplan–Meier method and compared using the log-rank test. Multivariate analyses of prognostic factors related to survival were performed using the Cox proportional hazards test. Statistical significance was set at a p < 0.05. All statistical analyses were performed with EZR (Saitama Medical Center, Jichi Medical University, Saitama, Japan), a graphical user interface for R (The R Foundation for Statistical Computing, Vienna, Austria) [11].

Results

The relationship of PNI with clinicopathological factors in patients with gallbladder cancer

The clinicopathological characteristics of the patients included in the present study are summarized in Table 1. PNI adjacent to the tumor lesion was detected in 13 of the 50 cases (26.0%). Representative photomicrographic images of PNI are shown in Fig. 1. PNI was correlated significantly with male sex (p = 0.021), presence of postoperative chemotherapy (p < 0.001), presence of postoperative complications (p = 0.049), proximal-type tumor (p = 0.003), lymphatic invasion (p = 0.003), vascular invasion (p < 0.001), and advanced T stage (p = 0.010). PNI was not detected in patients with stage T1 cancer. PNI did not correlate with other clinicopathological factors such as N stage, numbers of resected lymph nodes, and lymph node ratio (Table 2).
Table 1

Clinicopathological characteristics of the 50 gallbladder cancer patients

CharacteristicsNumber of patients (%)
Age (years)
 < 7023 (46.0)
 70 ≦27 (54.0)
Gender
 Male17 (34.0)
 Female33 (66.0)
Size (mm)
 <3526 (52.0)
 35≦24 (48.0)
Circumferential tumor location
 Hepatic side32 (64.0)
 No hepatic side18 (36.0)
Tumor location
 Proximal20 (40.0)
 Distal30 (60.0)
Surgical approach
 EHBD resection (-)19 (38.0)
 EHBD resection (+)31 (62.0)
Postoperative complications
 No46 (92.0)
 Yes4 (8.0)
Postoperative chemotherapy
 No31 (62.0)
 Yes19 (38.0)
Liver resection
 No20 (40.0)
 Yes30 (60.0)
T category
 T114 (28.0)
 T229 (58.0)
 T37 (14.0)
N category
 N (-)37 (74.0)
 N (+)13 (26.0)
Perineural invasion
 No37 (74.0)
 Yes13 (26.0)

EHBD extrahepatic bile duct

Fig. 1

Representative photomicrographs of perineural invasion adjacent to tumor lesion; arrowhead indicates tumor and arrow indicates nerve

Table 2

Relationships between perineural invasion and clinicopathologic factors of gallbladder cancer patients

CharacteristicsPNI (−)PNI (+)p value
n = 37 (74.0%)n = 13 (26.0%)
Age (years)
 < 7015 (40.5)8 (61.5)0.215
 70 ≦22 (59.5)5 (38.5)
Gender
 Male9 (23.4)8 (61.5)0.021*
 Female28 (75.7)5 (38.5)
Postoperative chemotherapy
 No29 (78.4)2 (15.4)< 0.001*
 Yes8 (21.6)11 (84.6)
Postoperative complications
 No36 (97.3)10 (76.9)0.049*
 Yes1 (2.7)3 (23.1)
Size (mm)
 < 3520 (54.1)6 (46.2)0.751
 35 ≦17 (45.9)7 (53.8)
Circumferential tumor location
 Hepatic side21 (56.8)11 (84.6)0.098
 No hepatic side16 (43.2)2 (15.4)
Tumor location
 Proximal10 (27.0)10 (76.9)0.003*
 Distal27 (73.0)3 (23.1)
Lymphatic invasion
 No27 (73.0)3 (23.1)0.003*
 Yes10 (27.0)10 (76.9)
Vascular invasion
 No32 (86.5)3 (23.1)< 0.001*
 Yes5 (13.5)10 (76.9)
T category
 T114 (37.8)0 (0.0)0.010*
 T2, T323 (62.2)13 (100.0)
N category
 N (-)29 (78.4)8 (61.5)0.281
 N (+)8 (21.6)5 (38.5)
Number of resected lymph nodes6.325.000.494
Lymph node ratio0.240.210.791

PNI perineural invasion. Significant differences between samples are indicated as *p <0.05

Clinicopathological characteristics of the 50 gallbladder cancer patients EHBD extrahepatic bile duct Representative photomicrographs of perineural invasion adjacent to tumor lesion; arrowhead indicates tumor and arrow indicates nerve Relationships between perineural invasion and clinicopathologic factors of gallbladder cancer patients PNI perineural invasion. Significant differences between samples are indicated as *p <0.05

The prognostic impact of HH

The median follow-up period of the study cohort was 63 months. Figure 2 shows the survival curves stratified according to the PNI status. Briefly, the overall and disease-free survival rates were significantly lower in the PNI-positive patients compared with the PNI-negative patients (p < 0.005 and p < 0.001, respectively).
Fig. 2

Kaplan–Meier curves for a overall survival rates and b disease-free survival rates. ***p < 0.005 compared with PNI (−) group using the log-rank test. ****p < 0.001 compared with PNI (−) group using the log-rank test. PNI perineural invasion

Kaplan–Meier curves for a overall survival rates and b disease-free survival rates. ***p < 0.005 compared with PNI (−) group using the log-rank test. ****p < 0.001 compared with PNI (−) group using the log-rank test. PNI perineural invasion Univariate analysis identified lymphatic and vascular invasion as well as the N stage as significant prognostic factors, whereas age, sex, tumor size, tumor location, EHBD resection, and the T stage were not found to be significantly associated with prognosis (Table 3). Subsequent multivariate analysis demonstrated that the presence of PNI was an independent prognostic factor (p < 0.001), as were lymphatic invasion (p = 0.007) and N stage (p < 0.001) (Table 3).
Table 3

Univariate and multivariate disease-free survival analyses of prognostic factors

UnivariateMultivariate
Characteristicsp valueHazard ratio95% CIp value
Age years
 < 650.410NA
 65 ≦
Gender
 Male0.114NA
 Female
Size (mm)
 < 350.433NA
 35 ≦
Circumferential tumor location
 Hepatic side0.073NA
 No hepatic side
Tumor location
 Proximal0.500NA
 Distal
EHBD resection
 No0.352NA
 Yes
Liver resection
 No0.706NA
 Yes
Lymphatic invasion
 No0.056NA
 Yes
Vascular invasion
 No0.018*1
 Yes1.4650.201–3.0150.717
T category
 T10.177
 T2, T3NA
N category
 N (-)< 0.001*1
 N (+)13.243.759–46.64< 0.001*
Perineural invasion
 No< 0.001*1
 Yes11.962.594–55.14< 0.001*

EHBD, extrahepatic bile duct; CI, confidence interval; NA, not adopted. Significant differences between samples are indicated as *p <0.05

Univariate and multivariate disease-free survival analyses of prognostic factors EHBD, extrahepatic bile duct; CI, confidence interval; NA, not adopted. Significant differences between samples are indicated as *p <0.05 In this series, PNI was found in only three of the 30 cases with distal-type gallbladder cancer; all three patients were treated by cholecystectomy with EHBD resection. However, all patients developed various types of recurrences even after R0 resection; therefore, the extended procedures were found not to have clinical therapeutic efficacy in these patients.

Discussion

Malignant tumors develop and progress via various routes of spread including hematogenous and lymphatic dissemination and local invasion. Local invasion is generally divided into direct invasion with destruction of the existing tissues and tumor spread through the loose space with particular histologic nature. As a representative of the latter, spreading through perineural space, i.e., PNI, is widely recognized as an important adverse pathological feature of many malignancies including pancreatic, prostate, and neck cancers [12, 13]. In these cancer types, the presence of PNI is a well-known poor prognostic factor [12, 13]. Similarly, PNI is detected frequently in gallbladder cancer and acknowledged for its clinical significance [6, 9]. PNI was detected more frequently in hepatic-sided and proximal-type gallbladder cancer in the current study cohort. Furthermore, PNI was an independent prognostic factor. However, our analysis indicated that PNI was not correlated with lymph node metastasis although lymphatic vessels and lymph nodes are adjacent to the nerves and plexuses around the gallbladder and the EHBD. Results from several recent experimental studies suggested that tumor cells might have increased affinity for nerve [14], implicating PNI in arising from a reciprocal interaction between the tumor cells and the microenvironment of the host nerve. The mechanisms of progression through nerve fibers and the lymphatic route might be distinct. To support this possibility, there was no significant correlation between PNI and specific recurrence patterns such as lymphatic or local recurrence in the current study cohort (data not shown). Whether EHBD resection should be routinely performed in patients with gallbladder cancer remains controversial [5]. Some studies suggested that EHBD resection should be performed routinely during radical cholecystectomy [6, 15, 16], whereas others reported that EHBD resection did not improve prognosis [17-19]. D’ Angelica et al. suggested EHBD resection is appropriate when necessary to clear disease but are not mandatory in all cases [20]. We agree with this report. Moreover, they have reported that the median number of lymph nodes was similar regardless of whether EHBD resection had been performed, and lymphadenectomy plus EHBD resection was not associated with an improvement in survival [17, 20]. Therefore, routine EHBD resection was not associated with lymph node yield or survival. Recently, Kurahara et al. found that EHBD resection improved prognosis in patients with proximal-type gallbladder cancer [21]. Considering that EHBD resection in combination with cholecystectomy is recognized as extended wide resection for cases with spread through PNI, EHBD resection is not necessary for patients with stage T1 gallbladder cancer with no evidence of PNI. Conversely, PNI was rarely detected in distal-type gallbladder cancers. The lower frequency of PNI in distal-type tumors might be due to the sparse nerve networks in the distal lesion or might reflect a biological feature. Intraoperative pathological diagnosis for the proximal margin should be useful for the decision for performing EHBD resection. However, PNI cannot be diagnosed before surgery. Therefore, it is important to know that PNI is detected more frequently in proximal-type gallbladder cancer and rarely detected in distal-type cancer. All patients with PNI-positive distal-type gallbladder cancer developed recurrence despite the EHBD resection. In this study, there were no cases of R1 resection for not performing EHBD; however, two cases with PNI-positive distal-type gallbladder cancer were R1 resection despite performing EHBD resection (data not shown). These results indicate that EHBD resection in combination with cholecystectomy failed to provide prognostic benefit for those with distal-type gallbladder cancer. However, the number of distal-type gallbladder cancer was small in this study, and further studies are warranted to confirm that. If patients with PNI-positive distal-type gallbladder cancer obtain long-term prognosis by performing EHBD resection, EHBD resection should be performed even for patients with distal-type cancer. To the best of our knowledge, no studies to date evaluated the clinical significance of EHBD resection for gallbladder cancer in the context of PNI. Magnon et al. demonstrated that surgical sympathectomy prevented the early-phase prostate cancer development [22], whereas Zhao et al. demonstrated that surgical denervation of the stomach markedly reduced gastric tumor incidence and progression [23]. Total resection of the nerve tissues around the EHBD should be discussed in two aspects: survival benefit with total removal of the tumor cells around the nerve tissues and potential post-denervation effects on tumor development and progression. The current study demonstrated that EHBD resection in combination with cholecystectomy may not provide any overt survival benefits at least for certain subsets of patients with gallbladder cancer. However, this study has certain limitations. The number of cases analyzed was small, and multi-center large-scale investigations are necessary to confirm these results.

Conclusions

In conclusion, the current study clearly demonstrated the prognostic impact of PNI in patients with gallbladder cancer. We suggest that EHBD resection in combination with cholecystectomy may not be useful at least in patients with stage T1 disease and distal-type tumors from a perspective of PNI.
  23 in total

Review 1.  Evolving treatment strategies for gallbladder cancer.

Authors:  Matthew T Hueman; Charles M Vollmer; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2009-06-03       Impact factor: 5.344

2.  Extra-Hepatic Bile Duct Resection: an Insight in the Management of Gallbladder Cancer.

Authors:  Durgatosh Pandey; Pankaj Kumar Garg; N M L Manjunath; Jyoti Sharma
Journal:  J Gastrointest Cancer       Date:  2015-09

3.  Indication of extrahepatic bile duct resection for gallbladder cancer.

Authors:  Hiroshi Kurahara; Kosei Maemura; Yuko Mataki; Masahiko Sakoda; Satoshi Iino; Yota Kawasaki; Shinichiro Mori; Takaaki Arigami; Yuko Kijima; Hiroyuki Shinchi; Shoji Natsugoe
Journal:  Langenbecks Arch Surg       Date:  2017-09-05       Impact factor: 3.445

4.  Should the bile duct be preserved or removed in radical surgery for gallbladder cancer?

Authors:  T Kosuge; K Sano; K Shimada; J Yamamoto; S Yamasaki; M Makuuchi
Journal:  Hepatogastroenterology       Date:  1999 Jul-Aug

5.  Should the extrahepatic bile duct be resected for locally advanced gallbladder cancer?

Authors:  Yasuhito Shimizu; Masayuki Ohtsuka; Hiroshi Ito; Fumio Kimura; Hiroaki Shimizu; Akira Togawa; Hiroyuki Yoshidome; Atsushi Kato; Masaru Miyazaki
Journal:  Surgery       Date:  2004-11       Impact factor: 3.982

6.  Appraisal of surgical treatment for pT2 gallbladder carcinomas.

Authors:  Shohachi Suzuki; Yoshihiro Yokoi; Kiyotaka Kurachi; Keisuke Inaba; Shigeyasu Ota; Masaki Azuma; Hiroyuki Konno; Satoshi Baba; Satoshi Nakamura
Journal:  World J Surg       Date:  2004-01-08       Impact factor: 3.352

Review 7.  Hepatic nervous system and neurobiology of the liver.

Authors:  Kendal Jay Jensen; Gianfranco Alpini; Shannon Glaser
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

8.  Autonomic nerve development contributes to prostate cancer progression.

Authors:  Claire Magnon; Simon J Hall; Juan Lin; Xiaonan Xue; Leah Gerber; Stephen J Freedland; Paul S Frenette
Journal:  Science       Date:  2013-07-12       Impact factor: 47.728

Review 9.  Current Status on Cholangiocarcinoma and Gallbladder Cancer.

Authors:  Tomoki Ebata; Giorgio Ercolani; Domenico Alvaro; Dario Ribero; Luca Di Tommaso; Juan W Valle
Journal:  Liver Cancer       Date:  2016-11-29       Impact factor: 11.740

10.  Long-Term Outcomes and Prognostic Factors in Advanced Gallbladder Cancer: Focus on the Advanced T Stage.

Authors:  Chen Chen; Zhimin Geng; Haoxin Shen; Huwei Song; Yaling Zhao; Guanjun Zhang; Wenzhi Li; Li Ma; Lin Wang
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

View more
  5 in total

1.  Perineural invasion is a prognostic factor in stage II colorectal cancer but not a treatment indicator for traditional chemotherapy: a retrospective cohort study.

Authors:  Juan Li; Shiwen Mei; Sichen Zhou; Fuqiang Zhao; Qian Liu
Journal:  J Gastrointest Oncol       Date:  2022-04

2.  A Novel Prognostic Nomogram for Gallbladder Cancer after Surgical Resection: A Single-Center Experience.

Authors:  Zuyi Ma; Fengying Dong; Zhenchong Li; Zehao Zheng; Zixuan Zhou; Hongkai Zhuang; Chunsheng Liu; Bowen Huang; Shanzhou Huang; Yiping Zou; LinLing Yang; Yuanfeng Gong; Chuanzhao Zhang; Baohua Hou
Journal:  J Oncol       Date:  2021-02-08       Impact factor: 4.375

Review 3.  Current and New Biomarkers for Early Detection, Prognostic Stratification, and Management of Gallbladder Cancer Patients.

Authors:  Patricia García; Angela Lamarca; Javier Díaz; Enrique Carrera; Juan Carlos Roa
Journal:  Cancers (Basel)       Date:  2020-12-07       Impact factor: 6.639

4.  Multimodality management of gallbladder cancer can lead to a better outcome: Experience from a tertiary care oncology centre in North India.

Authors:  Shaifali Goel; Abhishek Aggarwal; Assif Iqbal; Vineet Talwar; Swarupa Mitra; Shivendra Singh
Journal:  World J Gastroenterol       Date:  2021-12-07       Impact factor: 5.742

Review 5.  Schwann Cells in Digestive System Disorders.

Authors:  Karina Goluba; Liga Kunrade; Una Riekstina; Vadims Parfejevs
Journal:  Cells       Date:  2022-02-28       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.